Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
60
BMRN Quote, Financials, Valuation and Earnings
Last price:
$65.65
Seasonality move
:
5.39%
Day range:
$64.07 - $66.27
52-week range:
$61.15 - $99.25
Dividend yield:
0%
P/E ratio:
39.34x
P/S ratio:
4.69x
P/B ratio:
2.31x
Volume:
3.6M
Avg. volume:
1.5M
1-year change:
-29.11%
Market cap:
$12.5B
Revenue:
$2.4B
EPS (TTM):
$1.67
Earnings Data
Next earnings date for BMRN
Feb 21
2025
Most recent earnings per share
$0.55
Missed by $0.24
(Oct 29/2024)
Consensus Estimate
$0.79
(Oct 29/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BMRN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | $710.2M | -- | -- | $0.71 | -- |
| 10/29/2024 | Q3 | $703.3M | $745.7M | $0.55 | $0.79 | -$0.24 |
| 08/05/2024 | Q2 | $664M | $712M | $0.55 | $0.60 | -$0.05 |
| 04/24/2024 | Q1 | $651.8M | $648.8M | $0.46 | $0.60 | -$0.14 |
| 02/22/2024 | Q4 | $636.9M | $646.2M | $0.11 | $0.45 | -$0.34 |
| 11/01/2023 | Q3 | -- | -- | $0.21 | $0.48 | -$0.27 |
| 07/31/2023 | Q2 | -- | -- | $0.29 | $0.47 | -$0.18 |
| 04/26/2023 | Q1 | -- | -- | $0.27 | $0.40 | -$0.13 |
| 02/27/2023 | Q4 | -- | -- | -$0.00 | $0.39 | -$0.39 |
| 10/26/2022 | Q3 | -- | -- | -$0.04 | $0.43 | -$0.47 |
| 08/03/2022 | Q2 | -- | -- | $0.15 | $0.53 | -$0.38 |
| 04/27/2022 | Q1 | -- | -- | $0.63 | $0.46 | $0.18 |
| 02/23/2022 | Q4 | -- | -- | -$0.32 | -$0.01 | -$0.31 |
| 10/27/2021 | Q3 | -- | -- | -$0.20 | $0.09 | -$0.29 |
| 07/28/2021 | Q2 | -- | -- | $0.07 | $0.25 | -$0.18 |
| 04/29/2021 | Q1 | -- | -- | $0.09 | $0.30 | -$0.21 |
| 02/25/2021 | Q4 | -- | -- | $0.12 | $0.18 | -$0.06 |
| 11/05/2020 | Q3 | -- | -- | $4.01 | $0.26 | $3.75 |
| 08/04/2020 | Q2 | -- | -- | -$0.16 | $0.20 | -$0.36 |
| 04/30/2020 | Q1 | -- | -- | $0.44 | $0.33 | $0.11 |
| 02/26/2020 | Q4 | -- | -- | $0.08 | $0.24 | -$0.16 |
| 10/23/2019 | Q3 | -- | -- | $0.30 | $0.34 | -$0.04 |
| 08/01/2019 | Q2 | -- | -- | -- | $0.19 | -- |
| 04/25/2019 | Q1 | -- | -- | -- | $0.10 | -- |
| 02/21/2019 | Q4 | -- | -- | -- | $0.12 | -- |
| 10/25/2018 | Q3 | -- | -- | -- | $0.15 | -- |
| 08/02/2018 | Q2 | -- | -- | -- | -- | -- |
| 04/25/2018 | Q1 | -- | -- | -- | -- | -- |
| 02/22/2018 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/02/2017 | Q2 | -- | -- | -- | -- | -- |
| 05/04/2017 | Q1 | -- | -- | -- | -- | -- |
| 02/23/2017 | Q4 | -- | -- | -- | -- | -- |
| 10/27/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -- | -- | -- |
| 04/12/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2015 | Q2 | -- | -- | -- | -- | -- |
| 04/30/2015 | Q1 | -- | -- | -- | -- | -- |
| 02/25/2015 | Q4 | -- | -- | -- | -- | -- |
Biomarin Pharmaceutical Earnings Questions
-
How Much did Biomarin Pharmaceutical Generate in Revenue Last Quarter?
Biomarin Pharmaceutical reported $745.7M worth of top line sales in its most recent quarter.
-
Did Biomarin Pharmaceutical Beat Earnings Last Quarter?
Biomarin Pharmaceutical announced earnings per share of $0.55 which represents a miss of analyst forecast a $0.79 per share.
-
Is Biomarin Pharmaceutical Profitable?
Biomarin Pharmaceutical reported $557.3M that represents $2.83 per share over the last quarter.
-
What is the Analyst Consensus for Biomarin Pharmaceutical EPS Next Year?
Biomarin Pharmaceutical's earnings are forecast to grow from $0.87 per share to $2.04 per share next year representing an increase of 277.8%.
-
When is Biomarin Pharmaceutical's Earnings Date?
Biomarin Pharmaceutical's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
